Zalutumumab
From Wikipedia, the free encyclopedia
|
Zalutumumab?
|
|
| Therapeutic monoclonal antibody | |
| Source | Human |
| Target | ? |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | ? |
| Chemical data | |
| Formula | C6512H10074N1734O2032S46 |
| Mol. mass | 148 kD |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Zalutumumab is a human monoclonal antibody and which it is used to treat cancer.
|
||||||||||||||||||||||||||

